Bevacizumab in hereditary hemorrhagic telangiectasia

Prithviraj Bose; Jennifer L. Holter; George B. Selby

doi:10.1056/NEJMc0901421

Bevacizumab in hereditary hemorrhagic telangiectasia

Prithviraj Bose, Jennifer L. Holter, George B. Selby

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2143-2144
Number of pages	2
Journal	New England Journal of Medicine
Volume	360
Issue number	20
DOIs	https://doi.org/10.1056/NEJMc0901421
State	Published - May 14 2009
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc0901421

Cite this

@article{33398aa87e9c4d4d80dcaf91b0c8b730,

title = "Bevacizumab in hereditary hemorrhagic telangiectasia",

author = "Prithviraj Bose and Holter, {Jennifer L.} and Selby, {George B.}",

year = "2009",

month = may,

day = "14",

doi = "10.1056/NEJMc0901421",

language = "English (US)",

volume = "360",

pages = "2143--2144",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "20",

}

TY - JOUR

T1 - Bevacizumab in hereditary hemorrhagic telangiectasia

AU - Bose, Prithviraj

AU - Holter, Jennifer L.

AU - Selby, George B.

PY - 2009/5/14

Y1 - 2009/5/14

UR - http://www.scopus.com/inward/record.url?scp=65649124507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649124507&partnerID=8YFLogxK

U2 - 10.1056/NEJMc0901421

DO - 10.1056/NEJMc0901421

M3 - Letter

C2 - 19439755

AN - SCOPUS:65649124507

SN - 0028-4793

VL - 360

SP - 2143

EP - 2144

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 20

ER -

Bevacizumab in hereditary hemorrhagic telangiectasia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this